Cargando…

Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma

BACKGROUND: The role of unresected small lymph nodes (LNs) which may contain metastases for thoracic esophageal squamous cell carcinoma (TESCC) has not been addressed. The aim of the study was to investigate the role of unresected small LNs assessment using computed tomography (CT) in prognostic est...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yi, Xiao, Ping, Yang, Ningjing, Wang, Xiang, Ma, Ke, Wu, Lei, Zhang, Wei, Zhuang, Xiang, Xie, Tianpeng, Fang, Qiang, Lan, Mei, Wang, Qifeng, Peng, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522218/
https://www.ncbi.nlm.nih.gov/pubmed/34657600
http://dx.doi.org/10.1186/s12957-021-02412-1
_version_ 1784585048164401152
author Wang, Yi
Xiao, Ping
Yang, Ningjing
Wang, Xiang
Ma, Ke
Wu, Lei
Zhang, Wei
Zhuang, Xiang
Xie, Tianpeng
Fang, Qiang
Lan, Mei
Wang, Qifeng
Peng, Lin
author_facet Wang, Yi
Xiao, Ping
Yang, Ningjing
Wang, Xiang
Ma, Ke
Wu, Lei
Zhang, Wei
Zhuang, Xiang
Xie, Tianpeng
Fang, Qiang
Lan, Mei
Wang, Qifeng
Peng, Lin
author_sort Wang, Yi
collection PubMed
description BACKGROUND: The role of unresected small lymph nodes (LNs) which may contain metastases for thoracic esophageal squamous cell carcinoma (TESCC) has not been addressed. The aim of the study was to investigate the role of unresected small LNs assessment using computed tomography (CT) in prognostic estimates of pT3N0M0 TESCC patients. METHODS: Between January 2009 and December 2017, 294 patients who underwent esophagectomy with R0 resection at Sichuan Cancer Hospital were retrospectively examined, and the last follow-up time was July 2018. Patients were classified into CT-suspect and CT-negative groups according to the shortest diameter and the shape (axial ratio) of the unresected small LNs on preoperative CT. The Kaplan–Meier method was used to compare survival differences in prognostic factors. Univariate and multivariate analyses were performed to identify prognostic factors for survival and recurrence. RESULTS: Eighty-four patients (28.6%) were classified as CT-suspect group according to the diagnostic criteria; survival analysis suggested that CT-suspect group of patients had a relatively poorer prognosis (P<0.05). Cox regression analysis indicated that unresected small LNs status, tumor grade, and postoperative adjuvant therapy were independent prognostic factors for patients with pT3N0M0 TESCC (P<0.05). Further analysis shown the rates of total recurrence (TR) and locoregional recurrence (LR) in the CT-suspect group were significantly higher than that in the CT-negative group (TR, P<0.001; LR, P<0.001). Among the LRs, the rate of supraclavicular lymph node recurrence in the CT-suspect group was significantly higher than that in the CT-negative group (P<0.001). CONCLUSIONS: Unresected small lymph node assessment is critically important and predict prognosis for pT3N0M0 TESCC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-021-02412-1.
format Online
Article
Text
id pubmed-8522218
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85222182021-10-21 Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma Wang, Yi Xiao, Ping Yang, Ningjing Wang, Xiang Ma, Ke Wu, Lei Zhang, Wei Zhuang, Xiang Xie, Tianpeng Fang, Qiang Lan, Mei Wang, Qifeng Peng, Lin World J Surg Oncol Research BACKGROUND: The role of unresected small lymph nodes (LNs) which may contain metastases for thoracic esophageal squamous cell carcinoma (TESCC) has not been addressed. The aim of the study was to investigate the role of unresected small LNs assessment using computed tomography (CT) in prognostic estimates of pT3N0M0 TESCC patients. METHODS: Between January 2009 and December 2017, 294 patients who underwent esophagectomy with R0 resection at Sichuan Cancer Hospital were retrospectively examined, and the last follow-up time was July 2018. Patients were classified into CT-suspect and CT-negative groups according to the shortest diameter and the shape (axial ratio) of the unresected small LNs on preoperative CT. The Kaplan–Meier method was used to compare survival differences in prognostic factors. Univariate and multivariate analyses were performed to identify prognostic factors for survival and recurrence. RESULTS: Eighty-four patients (28.6%) were classified as CT-suspect group according to the diagnostic criteria; survival analysis suggested that CT-suspect group of patients had a relatively poorer prognosis (P<0.05). Cox regression analysis indicated that unresected small LNs status, tumor grade, and postoperative adjuvant therapy were independent prognostic factors for patients with pT3N0M0 TESCC (P<0.05). Further analysis shown the rates of total recurrence (TR) and locoregional recurrence (LR) in the CT-suspect group were significantly higher than that in the CT-negative group (TR, P<0.001; LR, P<0.001). Among the LRs, the rate of supraclavicular lymph node recurrence in the CT-suspect group was significantly higher than that in the CT-negative group (P<0.001). CONCLUSIONS: Unresected small lymph node assessment is critically important and predict prognosis for pT3N0M0 TESCC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-021-02412-1. BioMed Central 2021-10-18 /pmc/articles/PMC8522218/ /pubmed/34657600 http://dx.doi.org/10.1186/s12957-021-02412-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Yi
Xiao, Ping
Yang, Ningjing
Wang, Xiang
Ma, Ke
Wu, Lei
Zhang, Wei
Zhuang, Xiang
Xie, Tianpeng
Fang, Qiang
Lan, Mei
Wang, Qifeng
Peng, Lin
Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
title Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
title_full Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
title_fullStr Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
title_full_unstemmed Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
title_short Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma
title_sort unresected small lymph node assessment predicts prognosis for patients with pt3n0m0 thoracic esophageal squamous cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522218/
https://www.ncbi.nlm.nih.gov/pubmed/34657600
http://dx.doi.org/10.1186/s12957-021-02412-1
work_keys_str_mv AT wangyi unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT xiaoping unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT yangningjing unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT wangxiang unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT make unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT wulei unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT zhangwei unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT zhuangxiang unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT xietianpeng unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT fangqiang unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT lanmei unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT wangqifeng unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma
AT penglin unresectedsmalllymphnodeassessmentpredictsprognosisforpatientswithpt3n0m0thoracicesophagealsquamouscellcarcinoma